These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2904826)

  • 1. Effect of cicloprolol in intraocular pressure in healthy volunteers.
    Mekki QA; Turner P
    Br J Clin Pharmacol; 1988 Jul; 26(1):89-91. PubMed ID: 2904826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of the agonist and antagonist activity of cicloprolol in man.
    McCaffrey PM; Burke M; Riddell JG; Shanks RG
    Eur J Clin Pharmacol; 1988; 34(6):569-75. PubMed ID: 3169110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of the safety of the beta-modulator cicloprolol in chronic heart failure.
    Cocco G; Alfiero R; Pouleur H
    Clin Cardiol; 1992 Jan; 15(1):38-42. PubMed ID: 1347258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined invasive and noninvasive study of left ventricular systolic and diastolic function following acute administration of cicloprolol to subjects with normal cardiac function.
    Bonandi L; Metra M; Niccoli L; Ettori F; Nodari S; Dei Cas L; Visioli O
    Cardiovasc Drugs Ther; 1992 Oct; 6(5):513-7. PubMed ID: 1360256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.
    McCaffrey PM; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1987 Nov; 24(5):571-80. PubMed ID: 2893634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of esmolol and dexmedetomidine for attenuation of intraocular pressure and haemodynamic responses to laryngoscopy and tracheal intubation.
    Yavascaoglu B; Kaya FN; Baykara M; Bozkurt M; Korkmaz S
    Eur J Anaesthesiol; 2008 Jun; 25(6):517-9. PubMed ID: 18237451
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of CGP 17/582, a selective beta-adrenoceptor antagonist, on the haemodynamic and hypokalaemic response to adrenaline.
    Whyte KF; De Vane PJ; Whitesmith R; Kelman A; Reid JL
    Br J Clin Pharmacol; 1989 May; 27(5):553-61. PubMed ID: 2569322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic without pharmacokinetic interaction between cicloprolol, a partial beta 1-adrenoceptor agonist, and digoxin in healthy subjects.
    Weber S; Kahan A; Pinquier JL; Julien J; Rosenzweig P; Bianchetti G; Morselli PL; Dessault O; De Lauture D; Strauch G
    Br J Clin Pharmacol; 1990 Sep; 30(3):411-6. PubMed ID: 1977438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of orally administered nadolol on the intraocular pressure in normal volunteers.
    Williamson J; Atta HR; Kennedy PA; Muir JG
    Br J Ophthalmol; 1985 Jan; 69(1):38-40. PubMed ID: 2856892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular effects of single oral doses of the new beta-adrenoceptor blocking agents betaxolol (SL 75212) in healthy volunteers.
    Cadigan PJ; London DR; Pentecost BL; Bianchetti G; Gomeni R; Kilborn JR; Morselli PL
    Br J Clin Pharmacol; 1980 Jun; 9(6):569-75. PubMed ID: 6104498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of beta-adrenoceptor agents on the blood flow in carotid arteries in normal volunteers.
    Fitzgerald DE; Harry JD
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):73S-74S. PubMed ID: 2572260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Demonstration in healthy volunteers of the partial agonist effect of a cardioselective beta-blocker, cicloprolol].
    Grilliat JP; Le Van D; Mayeux D; Régnier F; Thiercelin JF; Thenot JP; Orofiamma B; Larribaud J
    Therapie; 1987; 42(6):519-24. PubMed ID: 2894724
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of nipradilol, an alpha-beta blocker, on retinal blood flow in healthy volunteers.
    Kida T; Sugiyama T; Harino S; Kitanishi K; Ikeda T
    Curr Eye Res; 2001 Aug; 23(2):128-32. PubMed ID: 11840351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
    Pringle TH; O'Connor PC; McNeill AJ; Finch MB; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1986 Mar; 21(3):249-58. PubMed ID: 2870732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lack of efficacy of topical beta-blockers, timolol and betaxolol on intraocular pressure in Nigerian healthy volunteers.
    Olateju SO; Ajayi AA
    Eye (Lond); 1999 Dec; 13 ( Pt 6)():758-63. PubMed ID: 10707140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of adimolol, labetalol and propranolol on heart rate and blood pressure in man.
    Riddell JG; Harron DW; Shanks RG
    Br J Clin Pharmacol; 1985 Apr; 19(4):405-10. PubMed ID: 2859871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular and cardiovascular response to topical carteolol 2% and timolol 0.5% in healthy volunteers.
    Brazier DJ; Smith SE
    Br J Ophthalmol; 1988 Feb; 72(2):101-3. PubMed ID: 3349009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of selective beta 2-adrenoceptor blockade on serum potassium and exercise performance in normal men.
    Gullestad L; Birkeland K; Nordby G; Larsen S; Kjekshus J
    Br J Clin Pharmacol; 1991 Aug; 32(2):201-7. PubMed ID: 1681847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic and systemic side effects of ocular beta-adrenergic antagonists in anesthetized dogs.
    Svec AL; Strosberg AM
    Invest Ophthalmol Vis Sci; 1986 Mar; 27(3):401-5. PubMed ID: 2869005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.